*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Bio-Response/NNP Inc./NNP ]
said/VBD 
[ it/PRP ]
filed/VBD for/IN 
[ protection/NN ]
under/IN 
[ Chapter/NNP 11/CD ]
of/IN 
[ the/DT federal/JJ Bankruptcy/NNP Code/NNP ]
./. 

======================================

[ The/DT filing/NN was/VBD n't/RB ]

[ a/DT surprise/NN ]
as/IN 
[ the/DT company/NN ]
said/VBD 
[ last/JJ week/NN ]
that/IN 
[ it/PRP ]
believed/VBD 
[ a/DT Chapter/NNP 11/CD ]
filing/NN was/VBD imminent/JJ because/IN of/IN 
[ an/DT inability/NN ]
to/TO meet/VB 
[ financial/JJ obligations/NNS ]
to/TO 
[ debenture/NN holders/NNS ]
./. 

Under/IN 
[ Chapter/NNP 11/CD ]
,/, 
[ a/DT company/NN ]
is/VBZ protected/VBN from/IN 
[ creditors/NNS ]
while/IN 
[ it/PRP ]
works/VBZ out/RP 
[ a/DT plan/NN ]
to/TO pay/VB 
[ its/PRP$ debt/NN ]
./. 

======================================

More/JJR than/IN 
[ 95/CD %/NN ]
of/IN 
[ its/PRP$ debentures/NNS outstanding/JJ ]
were/VBD tendered/VBN for/IN 
[ redemption/NN ]
by/IN 
[ the/DT company/NN ]
on/IN 
[ Sept./NNP 1/CD ]
at/IN 
[ an/DT aggregate/JJ redemption/NN price/NN ]
of/IN about/RB 
[ $/$ 22.4/CD million/CD ]
./. 

[ The/DT biotechnology/NN concern/NN ]
said/VBD 
[ it/PRP ]
attempted/VBD to/TO seek/VB 
[ an/DT arrangement/NN ]
with/IN 
[ debenture/NN holders/NNS ]

[ that/WDT ]
would/MD permit/VB 
[ the/DT company/NN ]
to/TO operate/VB 
[ outside/IN bankruptcy/NN proceedings/NNS ]
,/, but/CC 
[ the/DT firm/NN ]
said/VBD 
[ those/DT efforts/NNS ]
were/VBD unsuccessful/JJ ./. 

======================================

[ Bio-Response/NNP ]
,/, 
[ which/WDT ]
develops/VBZ 
[ commercial/JJ applications/NNS ]
of/IN 
[ products/NNS ]
derived/VBN from/IN 
[ mamalian/JJ cells/NNS ]
,/, said/VBD 
[ the/DT filing/NN ]
would/MD n't/RB interfere/VB with/IN existing/JJ 
[ projects/NNS ]
./. 

[ The/DT company/NN ]
said/VBD 
[ it/PRP ]
has/VBZ 
[ a/DT backlog/NN ]
of/IN 
[ orders/NNS ]
amounting/VBG to/TO nearly/RB 
[ $/$ 1/CD million/CD ]
./. 

======================================

[ It/PRP ]
also/RB said/VBD 
[ it/PRP ]
intensified/VBD 
[ its/PRP$ efforts/NNS ]
to/TO find/VB 
[ a/DT buyer/NN ]
for/IN 
[ the/DT company/NN ]
,/, but/CC 
[ was/VBD n't/RB more/RBR specific/NN ]
./. 
